For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Zeneca Limited

USPTO Granted Patents = 854

CIPO Patents = 10

Trademarks = 49

Forward Citations = 10,816

Loading Chart...

Loading Chart...

900 inventors (with patents filed for the assignee):

Peter Gregory (39 out of 77 patents)

Stephen Martin Brown (23 out of 33 patents)

Scott Carson Miller (23 out of 25 patents)

4. Wolfgang Walter Schuch (22 out of 32 patents)

5. Ronald W Kenyon (21 out of 39 patents)

6. Martin Charles Bowden (18 out of 29 patents)

7. Roger Salmon (17 out of 41 patents)

8. Chris Allan Veale (17 out of 18 patents)

9. George R Brown (17 out of 40 patents)

10. Andrew John Barker (16 out of 23 patents)

11. Sarah Bronwen Rees (16 out of 20 patents)

12. Christopher R Godfrey (16 out of 67 patents)

13. Willem F Broekaert (16 out of 44 patents)

14. Peter R Bernstein (16 out of 27 patents)

15. Prahalad Manibhai Mistry (15 out of 30 patents)

Core Competencies:

Aminoheterocyclic Derivatives

Antithrombotic Agents

Quinazoline Derivatives

Farnesyl Protein Transferase Inhibitors

Prostaglandin Antagonists

Biocidal Proteins

Antibiotic Compounds

Oxido-Squalene Cyclase Inhibitors

Indole Derivatives

Heterocyclic Compounds

Angiotensin II Antagonists

Antifungal Proteins

854 patents: Sort by Forward Citations

1. 7173025 - Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents (2007-02-06),

2. RE38916 - APC Antibodies (2005-12-05),

3. 6953809 - Monocyte chemoattractant protein-1 inhibitor compounds (2005-10-11),

4. 6946468 - 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors (2005-09-20),

5. 6897214 - Quinazoline derivatives (2005-05-24),

6. 6897210 - Quinazoline derivatives and pharmaceutical compositions containing them (2005-05-24),

7. 6787562 - Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists (2004-09-07),

8. 6767571 - Flavoring agent from filamentous fungus (2004-07-27),

9. 6737424 - Alpha-substituted pyridazino quinoline compounds (2004-05-18),

10. 6730672 - Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents (2004-05-04),

11. 6686467 - Amide derivatives for the treatment of diseases mediated by cytokines (2004-02-03),

12. 6680183 - Production of optically active 2-substituted tetrahydropyran-4-ones (2004-01-20),

13. 6673803 - Quinazoline derivatives and pharmaceutical compositions containing them (2004-01-06),

14. 6608208 - Process for the preparation of 1,2-benzisothiazolin-3-ones (2003-08-19),

15. 6579553 - Flavoring materials from filamentous fungi (2003-06-17),

Zeneca Limited is a global pharmaceutical company that focuses on the research, development, and commercialization of innovative medicines. With a diverse portfolio of products, Zeneca Limited strives to improve the health and well-being of people worldwide. They are committed to scientific advancement and collaborate with healthcare professionals and partners to bring groundbreaking treatments to patients. Visit their website to learn more about their mission, products, and initiatives in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

854 Patents

#4 in London

#13 in United Kingdom

#1,139 in the World

London, United Kingdom

Zeneca Limited

Forward Citations = 10,816

900 inventors:

Peter Gregory (39 out of 77 patents)

Stephen Martin Brown (23 out of 33 patents)

Scott Carson Miller (23 out of 25 patents)

4. Wolfgang Walter Schuch (22 out of 32 patents)

5. Ronald W Kenyon (21 out of 39 patents)

Please report any incorrect information to support@idiyas.com

Loading…